Drugs / Natural Killer (NK) Lymphocytes
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00328861 | May 2006 → Jul 2007 | kidney cancer, metastatic melanoma | National Cancer Institute (NCI) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Natural Killer (NK) Lymphocytes | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00328861 ↗ |
| Modality | Cell therapy | “autologous natural killer (NK) cells” NCT00328861 ↗ |
| Route | Intravenous | “Patients receive a 30-minute IV infusion of NK cells” NCT00328861 ↗ |